Merocytochalasans, Photocytochalasans and the Optical Control of the Actin Cytoskeleton
细胞松弛素、光细胞松弛素和肌动蛋白细胞骨架的光学控制
基本信息
- 批准号:9920728
- 负责人:
- 金额:$ 26.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAffinityBiological AvailabilityBiologyBiomimeticsCellsCellular biologyChemistryComplexCouplingCyclodepsipeptidesCytochalasinsCytoskeletonFamilyFamily memberFoundationsGoalsLifeLightMalignant NeoplasmsMolecularMolecular StructureNatural ProductsOpticsPyrogallolReactionRoleStructureStructure-Activity RelationshipUrsidae FamilyWorkanalogbasecancer cellcell typecytotoxicitydesignexperiencefascinateirradiationjasplakinolideprogramstoolvirtual
项目摘要
Merocytochalasans, Photocytochalasans, and the Optical Control of the Actin Cytoskeleton
Project Summary/Abstract
The goal of this project is to synthesize and study cytochalasans with new structural and functional features.
Cytochalasans generally target the actin cytoskeleton and account for some of the most potent natural products
known. New members of this family that combine fascinating molecular structures with interesting bioactivities,
such as the merocytochalasans, continue to emerge. We propose to synthesize these compounds and evaluate
them in depth for their effect on the actin cytoskeleton. To this end, we will develop biomimetic cascade reactions
that are based on the largely unexplored oxidative coupling chemistry of pyrogallols. In parallel, we will design
and synthesize cytochalasans that bear photoswitches and can be reversibly activated with light. These
“photocytochalasans” change their affinity, efficacy, or bioavailability upon irradiation and allow for the precision
control of actin dynamics. We will extend our program on the optical control of the actin cytoskeleton to
photoswitchable derivatives of the jasplakinolides. To support our claims, we provide preliminary results that
demonstrate that the photopharmacology of the actin cytoskeleton is indeed viable.
细胞松弛素、光细胞松弛素和肌动蛋白细胞骨架的光学控制
项目概要/摘要
该项目的目标是合成和研究具有新结构和功能特征的细胞松弛聚糖。
细胞松弛素通常以肌动蛋白细胞骨架为目标,并产生一些最有效的天然产物
已知。这个家族的新成员将迷人的分子结构与有趣的生物活性结合在一起,
例如merocytochalasans,不断出现。我们建议合成这些化合物并评估
深入研究它们对肌动蛋白细胞骨架的影响。为此,我们将开发仿生级联反应
它们基于很大程度上未经探索的连苯三酚氧化偶联化学。同时,我们将设计
并合成带有光开关并且可以被光可逆激活的细胞松弛聚糖。这些
“光细胞松弛素”在照射后会改变其亲和力、功效或生物利用度,并允许精确度
肌动蛋白动力学的控制。我们将把肌动蛋白细胞骨架的光学控制项目扩展到
jasplakinolides 的光可切换衍生物。为了支持我们的主张,我们提供了初步结果
证明肌动蛋白细胞骨架的光药理学确实可行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIRK HARTWIG TRAUNER其他文献
DIRK HARTWIG TRAUNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIRK HARTWIG TRAUNER', 18)}}的其他基金
Merocytochalasans, Photocytochalasans and the Optical Control of the Actin Cytoskeleton
细胞松弛素、光细胞松弛素和肌动蛋白细胞骨架的光学控制
- 批准号:
9752602 - 财政年份:2018
- 资助金额:
$ 26.57万 - 项目类别:
Total Synthesis of Biologically Active Gamma-Pyrones
生物活性γ-吡喃酮的全合成
- 批准号:
6596195 - 财政年份:2003
- 资助金额:
$ 26.57万 - 项目类别:
Total Synthesis of Biologically Active Gamma-Pyrones
生物活性γ-吡喃酮的全合成
- 批准号:
6890272 - 财政年份:2003
- 资助金额:
$ 26.57万 - 项目类别:
Total Synthesis of Biologically Active Gamma-Pyrones
生物活性γ-吡喃酮的全合成
- 批准号:
7227164 - 财政年份:2003
- 资助金额:
$ 26.57万 - 项目类别:
Total Synthesis of Biologically Active Gamma-Pyrones
生物活性γ-吡喃酮的全合成
- 批准号:
7060127 - 财政年份:2003
- 资助金额:
$ 26.57万 - 项目类别:
Total Synthesis of Biologically Active Gamma-Pyrones
生物活性γ-吡喃酮的全合成
- 批准号:
6744460 - 财政年份:2003
- 资助金额:
$ 26.57万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 26.57万 - 项目类别:
Continuing Grant